Defining a Rejuvenation Window: Dose‑Dependent p53‑Modulated Chromatin Noise Optimizes Epigenetic Age Reset Without Triggering Malignancy

Hypothesis\nTransient, dose‑dependent reduction of p53 activity creates a definable window of chromatin noise that maximizes epigenetic rejuvenation while preserving somatic identity; beyond this window, noise amplitude drives malignant transformation.\n\n## Mechanistic Model\np53 normally recruits SUV39H1 and HDAC complexes to deposit H3K9me3 and remove acetyl groups, keeping enhancer regions in a low‑accessibility state. When p53 is inhibited, SUV39H1 recruitment drops, leading to localized loss of H3K9me3 and a compensatory rise in H3K27ac via p300/CBP activity. This shift increases nucleosome turnover and ATAC‑seq signal at lineage‑inappropriate enhancers, producing the "epigenetic noise" observed in mTECs and during iPSC reprogramming. The noise amplitude correlates with the probability of activating pluripotency factors, thereby lowering epigenetic age as measured by Horvath‑pan‑tissue clocks. However, sustained high noise overwhelms the feedback loops that restrain oncogenic transcription (e.g., Myc, Ras), allowing stochastic activation of transformation programs.\n\n## Testable Predictions\n1. Optimal noise window – Using an inducible shRNA‑p53 system in human fibroblasts, a gradient of doxycycline concentrations will produce a bell‑shaped curve of epigenetic age reduction (ΔAge) measured at day 7 of reprogramming, with maximal rejuvenation at intermediate p53 knock‑down (~50 % protein level) and diminished returns at higher knock‑down (>80 %).\n2. Chromatin signature – ATAC‑seq performed at the optimal noise point will show a specific increase in accessibility at poised enhancers marked by H3K4me1/H3K27ac but not at constitutive heterochromatin, whereas excessive p53 loss will broaden accessibility to include pericentric repeats and oncogenic loci.\n3. Rejuvenation vs. transformation – Xenograft transplantation of cells harvested at the optimal noise point will retain somatic markers (e.g., collagen I) and form no tumors, while cells from the high‑noise condition will give rise to teratoma‑like growths with karyotypic abnormalities.\n4. Rescue experiment – Pharmacological inhibition of p300/CBP (e.g., A‑485) during high‑p53‑knockdown will reduce H3K27ac, lower noise amplitude, and restore the rejuvenation phenotype without increasing tumorigenicity.\n\n## Falsifiability\nIf epigenetic age reduction does not follow a dose‑responsive pattern with p53 levels, or if ATAC‑seq accessibility changes do not correlate with H3K9me3 loss and H3K27ac gain, the hypothesis is refuted. Likewise, failure to observe a clear separation between rejuvenative and tumorigenic outcomes across the noise gradient would invalidate the proposed mechanistic link.\n\n## References\n- p53 inhibition increases iPSC generation efficiency: PMC12577567\n- Epigenetic noise enables tissue‑specific gene expression in mTECs: UChicago news\n- Complete reprogramming decreases epigenetic age: bioRxiv 2024\n- Partial reprogramming induces steady epigenetic age decline: DOI 10.1111/acel.12877